FIMM has a driving mission to perform innovative research on patients and populations targeted towards understanding drivers of health and disease. We aim at delivering improvements to the safety, efficacy, and efficiency of healthcare in Finland and beyond.
We cordially invite you to join us in celebrating the start of a new and exciting decade of the Nordic EMBL Partnership for Molecular Medicine! The University of Helsinki, in collaboration with the European Molecular Biology Laboratory (EMBL), is thrilled to host a special event to celebrate the signing of the renewed agreement between EMBL and the Universities of Aarhus, Oslo, Umeå and Helsinki.
This new brochure describes some of our main scientific projects and achievements during the past few years and covers our key statistics. It also provides detailed information about our research programmes, infrastructure platforms, research training and other important aspects of FIMM.
As a translational institute, FIMM drives human-based research that has a profile of excellence at the highest level globally in terms of traditional metrics of publication, as well as leadership of international research efforts. We aim for our research to deliver, in a local context, direct health impact by bringing the results of research efforts to the Finnish population. Within the field of molecular medicine, FIMM focuses on ‘Grand Challenges’ that pursue our overall mission.